Reactivation of human herpesvirus-6 (HHV-6) frequently occurs following hematopoietic SCT (HSCT), and has been associated with clinical consequences in many patient populations. HHV-6 reactivation and ...

Before any treatment, each clinician and patient must determine whether the anticipated benefits outweigh the potential toll caused on the body. Study results published in Nature suggest that latent ...

For the first time, scientists have reconstructed ancient genomes of Human betaherpesvirus 6A and 6B (HHV-6A/B) from archaeological human remains more than two millennia old. The study, led by the ...

Human herpesvirus 6B (HHV-6B) glycoprotein complex which consists of gH/gL/gQ1/gQ2 is an effective vaccine candidate for HHV-6B. Currently, there is no prevention or treatment for HHV-6B infection.

Pneumonia is a major problem for patients undergoing bone marrow transplants. Despite testing for specific pathogens, up to 10% of transplant recipients are diagnosed with “idiopathic pneumonia ...

Human herpesvirus 6 is a common childhood infection, but for some people, the virus is inherited through the germline from a 24,000-year-old ancestor. An electron micrograph of human herpesvirus 6 ...

We describe an immunocompetent 61-year-old woman who was negative for human immunodeficiency virus and who had recurrent human herpesvirus 8 (HHV-8) infection associated with a relapsing systemic ...

Panel A shows May–Grunwald–Giemsa staining of blood plasmablasts (×100). Abnormal cells exhibited a plasmablastic morphology: a large nucleus with an irregular shape; fine, homogeneous chromatin and ...

Researchers have reconstructed ancient herpesvirus genomes from Iron Age and medieval Europeans, revealing that HHV-6 has been infecting humans for at least 2,500 years. Some people inherited the ...

A research group led by Professor MORI Yasuko (of the Division of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine) has revealed that the HHV-6B ...